NaturaLyte¿ Liquid Acid Concentrate for Bicarbonate Dialysis, 3.43 Liters, Part Number: 08-3231-1...
FDA Device Recall #Z-2110-2018 — Class II — May 2, 2018
Recall Summary
| Recall Number | Z-2110-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 2, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Fresenius Medical Care Renal Therapies Group, LLC |
| Location | Waltham, MA |
| Product Type | Devices |
| Quantity | 1060 cases (4240 bottles) |
Product Description
NaturaLyte¿ Liquid Acid Concentrate for Bicarbonate Dialysis, 3.43 Liters, Part Number: 08-3231-1 Product Usage: This concentrate is formulated to be used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine. For every 45 volume parts of dialysate: 1 volume part of the NaturaLyte acid concentrate, 1.72 volume parts of FMCNA Sodium Bicarbonate Concentrate and 42.28 volume parts of Purified Water (AAMI quality) are used.
Reason for Recall
The bottles are mislabeled with an incorrect part number.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states: CA, IA, IL, IN, KS, MD, MI, MN, MS, NE, NJ, NV, OK, PA, SD, TX, and WI.
Lot / Code Information
Lot Code: 18CXAC095
Other Recalls from Fresenius Medical Care Renal Therapie...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2151-2019 | Class II | Liberty Cycler Cassettes (a disposable cassette... | May 29, 2019 |
| Z-1699-2019 | Class III | 2008T BlueStar Machine Software v.2.72-Hemodial... | Apr 3, 2019 |
| Z-0658-2019 | Class II | Optiflux F160NR Capillary High Flux Dialyzer Si... | Nov 5, 2018 |
| Z-0516-2019 | Class III | Fresenius Granuflo Dry Acid Concentrate- 2K 2.0... | Oct 9, 2018 |
| Z-0517-2019 | Class III | Fresenius Granuflo Dry Acid Concentrate- 2K 2.5... | Oct 9, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.